|
|
Volumn 309, Issue 5735, 2005, Pages 735-
|
|
Pharma moves ahead cautiously in China: Companies can't resist the lure of China. But full-service research labs remain on the horizon.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
MEDICINE;
ARTICLE;
CHINA;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG RESEARCH;
DRUG SYNTHESIS;
ORGANIZATION;
PATENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
BIOMEDICAL RESEARCH;
CHEMISTRY, PHARMACEUTICAL;
CHINA;
CLINICAL TRIALS;
DRUG INDUSTRY;
INTELLECTUAL PROPERTY;
PHARMACEUTICAL PREPARATIONS;
RESEARCH PERSONNEL;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 23144449978
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.309.5735.735 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|